1 |
Kim JS, Yang J, Kim MJ. 2011. Alpha glucosidase inhibitory effect, anti-microbial activity and UPLC analysis of Rhus verniciflua under various extract conditions. J Med Plants Res 5: 778-783.
|
2 |
Palanuvej C, Hokputsa S, Tunsaringkarn T, Ruangrungsi N. 2009. In vitro glucose entrapment and alpha-glucosidase inhibition of mucilaginous substances from selected Thai medicinal plants. Sci Pharm 77: 837-849.
|
3 |
Baron AD. 1998. Postprandial hyperglycaemia and alpha-glucosidase inhibitors. Diabetes Res Clin Pract 40: S51-S55.
DOI
|
4 |
Ceriello A. 2005. Postprandial hyperglycemia and diabetes complications: is it time to treat?. Diabetes 54: 1-7.
DOI
|
5 |
Lee BH, Eskandari R, Jones K, Reddy KR, Quezada-Calvillo R, Nichols BL, Rose DR, Hamaker BR, Pinto BM. 2012. Modulation of starch digestion for slow glucose release through "toggling" of activities of mucosal -glucosidases. J Biol Chem 287: 31929-31938.
DOI
|
6 |
Jo SH, Ha KS, Moon KS, Lee OH, Jang HD, Kwon YI. 2011. In vitro and in vivo anti-hyperglycemic effects of Omija (Schizandra chinensis) fruit. Int J Mol Sci 12: 1359-1370.
DOI
|
7 |
Tadera K, Minami Y, Takamatsu K, Matsuoka T. 2006. Inhibition of -glucosidase and -amylase by flavonoids. J Nutr Sci Vitaminol 52: 149-153.
DOI
|
8 |
He K, Shi JC, Mao XM. 2014. Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients. Ther Clin Risk Manag 10: 505-511.
|
9 |
Derosa G, Maffioli P. 2012. -Glucosidase inhibitors and their use in clinical practice. Arch Med Sci 8: 899-906.
|
10 |
Joshi SR, Ramachandran A, Chadha M, Chatterjee S, Rathod R, Kalra S. 2014. Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes. Expert Opin Pharmacother 15: 1611-1620.
DOI
|
11 |
Katahira H, Ishida H. 2002. Indication and side effect of alpha glucosidase inhibitor. Nihon Rinsho 60: 399-408.
|
12 |
Kim MJ, Lee HJ, Wiryowidagdo S, Kim HK. 2007. Antihypertensive effects of Gynura procumbens extract in spontaneously hypertensive rats. J Med Food 9: 587-590.
|
13 |
Akowuah G, Ahmad M, Chin JH. 2009. The effect of extraction temperature on total phenols and antioxidant activity of Gynura procumbens leaf. Pharmacogn Mag 4: 81-85.
|
14 |
Iskander MN, Song Y, Coupar IM, Jiratchariyakul W. 2002. Antiinflammatory screening of the medicinal plant Gynura procumbens. Plant Foods Hum Nutr 57: 233-244.
DOI
|
15 |
Sunarwidhi AL, Sudarsono S, Nugroho AE. 2014. Hypoglycemic effect of combination of Azadirachta indica A. Juss. and Gynura procumbens (Lour.) Merr. ethanolic extracts standardized by rutin and quercetin in alloxan-induced hyperglycemic rats. Adv Pharm Bull 4: 613-618.
|
16 |
Kaewseejan N, Sutthikhum V, Siriamornpun S. 2015. Potential of Gynura procumbens leaves as source of flavonoid-enriched fractions with enhanced antioxidant capacity. J Funct Foods 12: 120-128.
DOI
|
17 |
Watanabe J, Kawabata J, Kurihara H, Niki R. 1997. Isolation and identification of -glucosidase inhibitors from tochu-cha (Eucommia ulmoides). Biosci Biotechnol Biochem 61: 177-178.
DOI
|
18 |
Abid S, Lekchiri A, Mekhfi H, Ziyyat A, Legssyer A, Aziz M, Bnouham M. 2014. Inhibition of -glucosidase and glucose intestinal absorption by Thymelaea hirsuta fractions. J Diabetes 6: 351-359.
DOI
|
19 |
Hara Y, Honda M. 1990. The inhibition of -amylase by tea polyphenols. Agric Biol Chem 54: 1939-1945.
|
20 |
Matsui T, Tanaka T, Tamura S, Toshima A, Tamaya K, Miyata Y, Tanaka K, Matsumoto K. 2007. -Glucosidase inhibitory profile of catechins and theaflavins. J Agric Food Chem 55: 99-105.
DOI
|
21 |
Hadrich F, Bouallagui Z, Junkyu H, Isoda H, Sayadi S. 2015. The -glucosidase and -amylase enzyme inhibitory of hydroxytyrosol and oleuropein. J Oleo Sci 64: 835-843.
DOI
|
22 |
Yang G, Shu XO, Jin F, Elasy T, Li HL, Li Q, Huang F, Zhang XL, Gao YT, Zheng W. 2004. Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study. Eur J Clin Nutr 58: 615-620.
DOI
|
23 |
Wang Y, Ma L, Li Z, Du Z, Liu Z, Qin J, Wang X, Huang Z, Gu L, Chen AS. 2004. Synergetic inhibition of metal ions and genistein on -glucosidase. FEBS Lett 576: 46-50.
DOI
|
24 |
Hong HC, Li SL, Zhang XQ, Ye WC, Zhang QW. 2013. Flavonoids with -glucosidase inhibitory activities and their contents in the leaves of Morus atropurpurea. Chin Med 8: 19.
DOI
|
25 |
Koskinen P, Manttari M, Manninen V, Huttunen JK, Heinonen OP, Frick MH. 1992. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15: 820-825.
DOI
|
26 |
Verges BL. 1999. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab 25: 32-40.
|
27 |
Lorber D. 2014. Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes 7: 169-183.
|
28 |
Ceriello A. 2004. Impaired glucose tolerance and cardiovascular disease: the possible role of post-prandial hyperglycemia. Am Heart J 147: 803-807.
DOI
|
29 |
Inoue I, Takahashi K, Noji S, Awata T, Negishi K, Katayama S. 1997. Acarbose controls postprandial hyperproinsulinemia in non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 36: 143-151.
DOI
|
30 |
Yale JF. 2005. Oral antihyperglycemic agents and renal disease: new agents, new concepts. J Am Soc Nephrol 16: S7-S10.
DOI
|